Retsevmo 40 mg, gélules
7680678620040
CH-67862
Kapseln
Associated product:
RETSEVMO caps 40 mg 56 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 56
- Selling units
- 56
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
selpercatinibum
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
lacca
|
- | Substance | HNIDK |
|
propylenglycolum
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
kalii hydroxidum
|
- | Substance | HNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 1560.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Eli Lilly (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 67862
- Drug name
- Retsevmo, gélules
- Galenic form
- KAHA
- ATC Code
- L01EX22
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 08/02/2021
- Authorization expiration date
- 19/12/2029
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- RETSEVMO caps 40 mg 56 pce
- Description (DE)
- RETSEVMO Kaps 40 mg 56 Stk
- Market launch
- 08/02/2021
- Market withdrawal
- 01/10/2026
- Narcotic (BTM)
- No
Other package sizes (5)
RETSEVMO caps 40 mg fl 60 pce
None None
GTIN: 7680678620019
RETSEVMO caps 80 mg fl 60 pce
None None
GTIN: 7680678620026
None
None None
GTIN: None
RETSEVMO caps 80 mg 56 pce
56 KAP
GTIN: 7680678620057
None
112 KAP
GTIN: None